|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Stock-based compensation expense | |||
| Depreciation expense | |||
| Change in fair value of preferred stock tranche liability | |||
| Change in fair value of anti-dilution liability | |||
| Noncash operating lease expense | |||
| Changes in operating assets and liabilities: | |||
| Prepaid expenses and other current assets | |||
| Other assets | |||
| Accounts payable | |||
| Accrued expenses and other current liabilities | |||
| Operating lease liabilities | |||
| Net cash used in operating activities | |||
| Cash flows from investing activities: | |||
| Purchase of property and equipment | |||
| Net cash used in investing activities | |||
| Cash flows from financing activities: | |||
| Proceeds from issuance of preferred stock, net of issuance costs | |||
| Payment of offering costs | |||
| Proceeds from issuance of common stock in initial public offering, net of issuance costs and underwriting fees | |||
| Proceeds from issuance of common stock through ATM sales, net of offering costs | |||
| Proceeds from the exercise of stock options | |||
| Net cash provided by financing activities | |||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||
| Cash, cash equivalents and restricted cash at beginning of period | |||
| Cash, cash equivalents and restricted cash at end of period | |||
| Supplemental disclosure of cash flows: | |||
| Right of use asset obtained in exchange for operating lease liability | |||
| Conversion of preferred stock into common stock | |||
| Preferred stock tranche liability established in connection with the issuance of redeemable convertible preferred stock | |||
| Issuance of redeemable convertible preferred stock in settlement of preferred stock tranche liability | |||
| Gain on extinguishment of preferred stock tranche liability record to additional paid in capital | |||
| Issuance of redeemable convertible preferred stock in settlement of anti-dilution right liability | |||
| Deferred offering costs reclassified to additional paid-in equity |
Loading...
